Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12623000514606Phase 4Recruiting
Phase 4 trial of nifedipine in postoperative pain (2 arms), sponsored by Steen Dermatology. Primary endpoint: Postoperative pain. Started Oct 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12623000514606.